STTK Shattuck Therapeutics Total Asset Value of Company
Shattuck Labs, Inc. (STTK) creates barriers for competitors through patents on ARC bifunctional proteins while operating under strict FDA oversight. The business's financial stability relies on exclusive rights to therapy methods for severe pathologies. This chart on the GURU.Markets platform shows that total assets amount to 142.54. The protection of immune alloys and large-scale R&D investments separate the company from smaller players.
Analytical breakdowns and data insights for company shattucklabs.com (STTK)
- market value and analyst target forecast:
- market capitalization data:
- issuer book value statistics:
- debt burden and liquidity indicators:
Fundamental valuation:Shattuck Labs, Inc.
Total assets represent the aggregate value of the company's resources and liabilities, calculated inversely via ROA to assess the issuer's fundamental base. In the context of implementing automated bioscreening systems at Shattuck Labs, Inc. (STTK), the growth of assets and resources on the GURU.Markets platform signals an expansion of the robotics technology park, allowing investors to determine the stage of innovation capitalization and the risk of overpaying for the stock.
Key competitors
argenx.com (ARGX) - Company Total Assets|Aggregate Company Assets BioNTech|Abivax - Total Asset Value of Company|Company Total Assets ADMA|PTGX (Protagonist Corp) - Aggregate Asset Value|Company Total Assets IMVT (Immunovant, Inc.)|Company Total Assets kiniksa.com KNSA|GRFS - Aggregate Company Assets|Aggregate Asset Value ADPT (Adaptive Biotech)|Celldex (CLDX) - Aggregate Company Assets|Cumulative Company Assets Aurinia Corp|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com|Cumulative Company Assets DNTH (Dianthus Therapeutics, Inc.)|PHVS (Pharvaris NV) - Aggregate Asset Value|Company Total Assets ABCL (abcellera.com)|Company Total Asset Base Tourmaline (TRML)|PGEN - Aggregate Company Assets|pharming.com (PHAR) - Cumulative Company Assets|Nektar Therapeutics Inc. (NKTR) - Aggregate Company Assets|Cumulative Company Assets Upstream Bio, Inc.|Cumulative Company Assets ZBIO|Company Total Assets Immunome Bio|Aggregate Company Assets Gossamer Bio, Inc. (GOSS)|kalvista.com - Total Business Assets|Company Total Assets SEPN (Septerna)|Pieris Pharma (PVLA) - Company Assets|SVRA - Aggregate Company Assets|Company Total Asset Base Rigel Corp RIGL|ANAB: Company Total Assets|astriatx.com - Aggregate Asset Value|ENGN (enGene) - Company Total Assets|Company Total Assets RAPT Therapeutics Inc.|Cumulative Company Assets JBIO (Aerovate Therapeutics Inc)|Aggregate Business Assets ACRS|Kyverna Therapeutics - Cumulative Company Assets|Aggregate Business Assets TLSA (tizianalifesciences.com)|CABA: Cumulative Company Assets|VTYX - Company Total Assets|THTX: Company Total Assets|Cumulative Company Assets Avalo Therapeutics Inc|Aggregate Company Assets Eledon Pharmaceuticals|Company Total Assets agenusbio.com|Cumulative Company Assets CLYM (Climb Bio)|ZURA (Zura Bio Ltd) - Aggregate Asset Value|Aggregate Company Assets aTyr ATYR|Adagene Inc - Aggregate Company Assets|Ikena Oncology, Inc. - Company Total Assets|EQ - Company Total Assets|CNTB: Company Total Assets|IMUX (Immunic) - Aggregate Company Assets|Aggregate Company Assets Atara Biotherapeutics, Inc.|InflaRx GmbH (IFRX) - Company Total Asset Base|Cumulative Company Assets XFOR (X4 Pharmaceuticals)|ACET (adicetbio.com) - Aggregate Asset Value|Company Total Assets CELU (Celularity)|Company Total Asset Base INmune Bio Inc (INMB)|BRNS - Aggregate Company Assets|KZR (Kezar Life Sciences Inc) - Total Business Assets|SABS: Company Total Assets|Cumulative Company Assets akaritx.com|Cumulative Company Assets ENLV|Q32 Bio Corp (QTTB) - Company Total Asset Base|Aggregate Company Assets GeoVax Labs Inc (GOVX)|Company Total Asset Base Edesa Biotech Corp|iBio, Inc. - Cumulative Company Assets|Aggregate Business Assets CARM (Carisma Therapeutics Inc)|XTLB: Cumulative Company Assets|Bolt Biotherapeutics - Aggregate Business Assets|hcwbiologics.com (HCWB) - Aggregate Company Assets|Aptevo Therapeutics Inc. (APVO) - Company Total Assets|Aggregate Company Assets AIM ImmunoTech Inc.|Aditxt Corp - Total Asset Value of Company|Company Total Assets GRI|XRTX (XORTX Therapeutics Inc) - Aggregate Asset Value|Company Total Assets HIND (ReShape Lifesciences)|Company Total Assets Revelation Biosciences Corp REVB|INDP - Aggregate Company Assets|Aggregate Asset Value SCNI (scinai.com)|calcimedica.com (CALI) - Aggregate Company Assets|Cumulative Company Assets Affimed N.V.|ALLK (Allakos Inc) - Company Total Assets|Company Total Assets HOOKIPA|Cumulative Company Assets IGMS (IGM Biosciences, Inc.)|ITOS (iteostherapeutics.com) - Aggregate Asset Value|Company Total Assets OCEA (Ocean Biomedical)|Company Total Asset Base TC BioPharm (Holdings) Plc (TCBP)|THRD - Aggregate Company Assets